APA

Saleh M. N., Lalisan D. Y., Pride M. W., Solinger A., Mayo M. S., LoBuglio A. F. & Murray J. L. (19981208). Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic disease. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Chicago

Saleh M N, Lalisan D Y, Pride M W, Solinger A, Mayo M S, LoBuglio A F and Murray J L. 19981208. Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic disease. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Harvard

Saleh M. N., Lalisan D. Y., Pride M. W., Solinger A., Mayo M. S., LoBuglio A. F. and Murray J. L. (19981208). Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic disease. : Journal of immunotherapy (Hagerstown, Md. : 1997).

MLA

Saleh M N, Lalisan D Y, Pride M W, Solinger A, Mayo M S, LoBuglio A F and Murray J L. Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic disease. : Journal of immunotherapy (Hagerstown, Md. : 1997). 19981208.